PMI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Picard Medical Inc (PMI) is not a strong buy for a beginner, long-term investor at this time. The technical indicators are neutral to bearish, and the company's financial performance shows declining net income and EPS despite revenue growth. Additionally, there are no strong positive catalysts or trading signals to suggest immediate upside potential.
The MACD is slightly positive but contracting, indicating limited momentum. RSI is neutral at 31.299, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support is at 0.858, and resistance is at 0.995. The stock has a 60% chance of declining -2.34% in the next day but could gain 4.29% in the next week and 7.21% in the next month.
Revenue increased 20.69% YoY in Q4 2025, and gross margin improved significantly to 40.73%. The company reported increased utilization of its SynCardia Total Artificial Heart in Q1 2026.
Insiders and hedge funds are neutral, with no significant trading trends. The stock's bearish moving averages and lack of strong trading signals further weigh on its attractiveness.
In Q4 2025, revenue grew to $1.009 million (up 20.69% YoY), but net income dropped to -$4.291 million (-54.87% YoY), and EPS declined to -0.06 (-53.85% YoY). Gross margin improved significantly to 40.73% (up 150.34% YoY).
No analyst rating or price target changes available.
